Consultants Page banner background.png



Automatically Find Hidden Issues That Cause Millions In Added Costs

Drastically Cut Costs With Real-time Insights

Within a moment, a perfectly managed account can take a sharp downward turn. All it takes is one high cost claim and costs can skyrocket. Xevant can identify this claim within a day, enabling account managers to manage that claim immediately instead of letting those costs rack up over the entire year. Real-time insights save hundreds of thousands of dollars.

Asset 1@4x.png

Why Xevant?

Full Transparency & PBM Oversight

Infrequent PBM reporting that focuses primarily on the successes isn’t enough to give you the full picture. Xevant analyzes and visualizes claims data to give you real-time insight into the PBMs performance with no biases at play. Have full transparency and instant access to the data you need for PBM oversight.


Save Time With Automated Reporting

With a click of a button, account executives can have a plan review generated and exported into PDF or PowerPoint, ready to use within 10 minutes. By automating the plan review process, account executives utilizing Xevant have more time to service their clients.


Better Client Management In Less Time

Boost client satisfaction and retention by automating time-consuming tasks like quarterly reviews, claims management, member research, and clinical management. Enable account executives to manage more clients in less time.


Expert Pharmacy Analysis

Along with insight into claims data, Xevant has a team of pharmacy experts who can assist with taking necessary action to prevent future claims problems. These experts know how to analyze the data, and know what steps to take to correct areas of concern.

Contract Management

830590_Simplified Graph_03_092420.png
  • Reduce claims costs by 3% (avg) by optimizing PBM contract guarantees and performance in real-time

  • Avoid the cost of full PBM audits costing $50K-$100K and 6 months of analysis if probability of audit success is low

  • Avoid cost of moving vendors by communicating and managing underperformance with consultant and PBM


Plan Management

Xevant gives you the power of real-time plan review without waiting 8-12 weeks for PBM. Identify problems sooner and save $430K.

855377_Xevant graphic redesign - plan ma

Specialty Co-Pay Assistance

  • 9% plan cost reduction without making changes to benefits plan

  • Real-time alerting and management of high-cost specialty drugs

  • 15% reduction in member costs from high-cost specialty drugs

  • Improved medication adherence associated with lower cost of therapy

830559_Statistic graphic_03_091420 (1).p
830643_Line graph visual2_02_091720.png

Product Mix Optimization

  • Acceleration of generic adoption through real-time generic rate alerting and analysis

  • 1.7% savings vs non-Xevant plan sponsors by reducing the time for full new generic adoption by 8 months

  • 2.3% member cost reduction over the same time frame


COVID-19 Patient Management

  • TPA for plan sponsor with 3,500 members identified over 300 members who were at-risk for COVID-19 but still actively working in public

  • Care coordination provided through TPA to move vulnerable members into home-based working environment

  • Member outcomes improved with lower infection and hospitalization rates

830627_Pie graph illustration_2_091420.p

New to Therapy Management


Formulary Optimization

Disruption analysis to determine the optimal formulary based on savings and member impact. Drive down costs and improve member outcomes.

RxAdherence Management

Identify non-adherent patients and intervene with patient management programs. Report increased cost due to non-adherence as well as savings based on adherence monitoring.

Network Management

Instant alerting of changes to utilization among channel including in-house pharmacies. Cost decreases through optimal channel.


Reprices claims in real-time within seconds across any number of PBM rate options. Since 2018, Xevant and clients using BidLogic have helped hundreds of plan sponsors save an aggregate of over $150M in drug spend.

Instant Claims Repricing